The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Improving Delivery of Parkinson's Disease Therapeutics to th, 2008Novel Antibodies for the Delivery of Parkinson's Therapeutics
Objective/Rationale:
Hindering drug development for neurological diseases like Parkinson’s disease is a lack of robust drug delivery strategies that can target medicines to the brain noninvasively via... -
Improving Delivery of Parkinson's Disease Therapeutics, 2008Utilizing Novel Tracers to Determine the Distribution of Therapeutic Agents In Vivo
Objective/Rationale:
This project will study the delivery and distribution of promising therapeutics for Parkinson’s disease. The explored compounds will be infused directly into the brain of npre... -
Improving Delivery of Parkinson's Disease Therapeutics to th, 2008Intranasal Delivery of GDNF for Parkinson's Disease: Next Steps
Objective/Rationale:
GDNF, a naturally-occurring growth factor capable of protecting and promoting the survival of dopamine neurons, has great potential as a treatment for Parkinson’s disease. However... -
MJFF Research Grant, 2008DNA Nanoparticle Therapy for Parkinson’s Disease
Promising Outcomes of Original Grant:
Recombinant plasmid DNA encoding for glial cell line-derived neurotrophic factor (GDNF) was compacted into nanoparticles, injected safely into the brain, and... -
Rapid Response Innovation Awards, 2008Screen for Drugs to Reduce ER Stress
Objective/Rationale:
Humans are exposed to agents and conditions that cause stress to dopaminergic neurons. Neurons can survive stress by modulating the biosynthesis and degradation of proteins within... -
Rapid Response Innovation Awards, 2008DNA Methylation as an Epigenetic Mechanism in the Etiopathogenesis of Parkinson's Disease
Objective/Rationale:
The objective of this research is to determine whether epigenetic factors play a role in the development of sporadic Parkinson’s disease. Epigenetic factors are chemical...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.